ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS)

Historical Holders from Q4 2017 to Q4 2025

Type / Class
Equity / Class A common stock, $0.00025 par value
Symbol
KIDS on Nasdaq
Shares outstanding
25,086,311
Price per share
$17.76
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
16,501,828
Total reported value
$305,775,919
% of total 13F portfolios
0%
Share change
-317,065
Value change
-$6,454,989
Number of holders
110
Price from insider filings
$17.76
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTEGRATED CORE STRATEGIES (US) LLC 5.5% $25,768,856 1,390,656 Millennium Management LLC 29 Oct 2025
BlackRock, Inc. 5% $28,406,495 1,230,784 BlackRock, Inc. 30 Jun 2025
BROWN CAPITAL MANAGEMENT LLC 4.3% -35% $20,035,007 -$10,919,822 1,081,220 -35% Brown Capital Management, LLC 30 Sep 2025
As of 30 Sep 2025, ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS) has 110 institutional shareholders filing 13F forms. They hold 16,501,828 shares. of 25,086,311 outstanding shares (66%) .

Top 25 institutional shareholders own 59% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BROWN ADVISORY INC 7.6% 1,894,705 +17% 0.05% $35,108,886
BlackRock, Inc. 4.8% 1,216,574 -2.1% 0% $22,543,117
MORGAN STANLEY 4.4% 1,111,448 -9.3% 0% $20,595,135
BRAIDWELL LP 4.4% 1,107,770 0% 0.61% $20,526,978
BROWN CAPITAL MANAGEMENT LLC 4.3% 1,081,220 -31% 0.83% $20,035,007
WELLINGTON MANAGEMENT GROUP LLP 4.1% 1,024,555 -0.21% 0% $18,985,004
VANGUARD GROUP INC 3.8% 961,330 +1.1% 0% $17,813,445
MILLENNIUM MANAGEMENT LLC 3.8% 943,655 +21% 0.01% $17,485,927
Granahan Investment Management, LLC 3% 759,951 -21% 0.58% $14,081,892
DIMENSIONAL FUND ADVISORS LP 2.9% 719,831 -1.5% 0% $13,338,081
AWM Investment Company, Inc. 2.2% 549,949 +3.5% 0.96% $10,190,555
MARSHALL WACE, LLP 1.8% 444,320 +6% 0.01% $8,233,250
STATE STREET CORP 1.7% 427,184 -0.29% 0% $7,915,720
GEODE CAPITAL MANAGEMENT, LLC 1.7% 417,852 +2% 0% $7,743,813
Prosight Management, LP 1.2% 308,707 +319% 1.4% $5,720,341
WASATCH ADVISORS LP 1.2% 304,111 -3.7% 0.03% $5,635,177
RIVERBRIDGE PARTNERS LLC 1.2% 293,864 -8.5% 0.09% $5,445,296
DEERFIELD MANAGEMENT COMPANY, L.P. 0.77% 194,109 +1153% 0.06% $3,596,840
NEW YORK STATE COMMON RETIREMENT FUND 0.76% 191,066 -57% 0% $3,540,453
PARADIGM CAPITAL MANAGEMENT INC/NY 0.72% 181,000 +6% 0.15% $3,353,930
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC 0.72% 179,410 -3% 0.04% $3,324,467
NORTHERN TRUST CORP 0.7% 175,023 -2.6% 0% $3,243,175
KENNEDY CAPITAL MANAGEMENT LLC 0.66% 165,513 -12% 0.07% $3,066,956
Triodos Investment Management BV 0.53% 132,500 +18% 0.18% $2,453,900
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.52% 131,115 -5.3% 0% $2,429,561

Institutional Holders of ORTHOPEDIATRICS CORP - Class A common stock, $0.00025 par value (KIDS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 305 $5,417 +$3,829 $17.76 1
2025 Q3 16,501,828 $305,775,919 -$6,454,989 $18.53 110
2025 Q2 16,817,981 $361,248,552 +$2,212,299 $21.48 116
2025 Q1 16,691,588 $411,125,423 +$5,143,020 $24.63 114
2024 Q4 16,501,550 $382,508,887 +$776,818 $23.18 107
2024 Q3 16,333,743 $442,837,473 +$1,496,187 $27.11 122
2024 Q2 16,245,522 $467,232,472 +$11,247,289 $28.76 121
2024 Q1 15,856,696 $462,382,808 -$12,314,873 $29.16 117
2023 Q4 24,325 $790,806 +$578,678 $32.51 2
2023 Q3 16,222,975 $519,129,153 +$6,467,363 $32.00 112
2023 Q2 15,967,571 $700,285,257 -$10,945,407 $43.85 119
2023 Q1 16,213,938 $717,721,921 +$13,552,242 $44.29 120
2022 Q4 15,921,205 $632,717,210 -$20,401,221 $39.73 115
2022 Q3 15,126,783 $698,016,616 +$7,526,371 $46.14 115
2022 Q2 15,126,417 $652,558,661 +$8,896,782 $43.15 111
2022 Q1 14,776,786 $797,826,443 +$16,778,841 $53.99 119
2021 Q4 14,421,925 $863,238,220 -$42,579,370 $59.86 120
2021 Q3 14,711,872 $963,955,425 -$16,152,359 $65.51 139
2021 Q2 15,028,598 $949,349,978 +$34,846,332 $63.18 134
2021 Q1 14,649,740 $714,164,975 -$10,430,324 $48.75 121
2020 Q4 14,704,495 $606,715,649 +$28,435,784 $41.25 126
2020 Q3 13,939,287 $640,120,617 +$41,098,888 $45.92 119
2020 Q2 13,071,781 $571,934,696 +$88,210,798 $43.76 127
2020 Q1 10,895,736 $431,849,875 +$57,455,803 $39.64 101
2019 Q4 9,512,953 $446,965,037 +$84,902,075 $46.99 104
2019 Q3 7,493,263 $264,236,326 +$9,641,130 $35.26 85
2019 Q2 7,169,160 $279,547,895 +$1,237,179 $39.00 97
2019 Q1 7,148,503 $316,165,724 +$23,432,675 $44.23 93
2018 Q4 6,619,441 $230,855,733 +$50,293,611 $34.88 74
2018 Q3 5,171,725 $189,455,535 +$5,645,330 $36.64 60
2018 Q2 5,137,377 $136,875,101 +$18,969,514 $26.64 53
2018 Q1 4,514,722 $67,991,229 +$3,721,628 $15.06 45
2017 Q4 4,157,700 $79,782,894 +$79,782,919 $19.19 48